calendar
111 catalysts · 4,110 phase readout · 2,205 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
111 catalysts · 4,110 phase readout · 2,205 8k filing · 282 earnings · 172 phase 2 completion · 110 drug shortage · 73 phase 1 completion
NS grant. $633,378. PI: Alba Miranda Azola
AI grant. $88,250. PI: Jennifer Lynn Hyde
AI grant. $440,211. PI: Julie Dunning Hotopp
ES grant. $605,091. PI: Yike Shen
NS grant. $429,000. PI: NAGI G AYAD
AI grant. $161,244. PI: TERESA GIL GIL
CA grant. $415,623. PI: STEPHEN J KADLECEK
AI grant. $267,000. PI: Qianxia Zhang
DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski
NR grant. $3,480,544. PI: Michelle Trivedi
ES grant. $795,869. PI: Sean M Harris
AI grant. $660,723. PI: Hongyan Guo
AI grant. $843,182. PI: Christopher F Basler
AT grant. $788,967. PI: ADAM L. Halberstadt
AI grant. $209,758. PI: Paul K Drain
AT grant. $601,259. PI: Ashley E. Mason
NS grant. $568,920. PI: Theresa Currier Thomas
CA grant. $496,357. PI: DANIEL J BRAT
AT grant. $170,640. PI: Julia E. Hooker
AI grant. $210,302. PI: William Evan Johnson
DK grant. $231,000. PI: Roger D. Cone
NS grant. $230,562. PI: Thuy Nguyen
ES grant. $117,747. PI: Rebecca Sugrue
Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus
Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19), Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
Therapy area: Dermatology. Indication: Chronic Urticaria
Therapy area: Immunology. Indication: Liver Transplant Rejection
Therapy area: Oncology. Indication: Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Follicular Lymphoma, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphomas (PTCL), T-Cell Lymphomas
Therapy area: Oncology. Indication: Neuroendocrine Cancer, Small-Cell Lung Cancer, Solid Tumor
Therapy area: Undisclosed. Indication: Unspecified
Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders
Therapy area: Central Nervous System. Indication: Schizophrenia, Unspecified Neurologic Disorders
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Immunology. Indication: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Therapy area: Immunology. Indication: Autoimmune Disorders, Diffuse Cutaneous Systemic Sclerosis, Systemic Sclerosis (Scleroderma)
Therapy area: Metabolic Disorders, Musculoskeletal Disorders. Indication: Gouty Arthritis (Gout), Hyperuricemia
Therapy area: Dermatology. Indication: Burns
Therapy area: Metabolic Disorders. Indication: Obesity, Overweight
Therapy area: Central Nervous System. Indication: Parkinson's Disease
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19)
Therapy area: Metabolic Disorders. Indication: Phenylketonuria (PKU)
Therapy area: Cardiovascular. Indication: Ischemic Stroke
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Therapy area: Central Nervous System. Indication: Huntington Disease, Tardive Dyskinesia
Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Congestive Heart Failure (Heart Failure), Deep Vein Thrombosis (DVT), Myocardial Infarction, Pulmonary Embolism, Thromboembolic Disease, Thromboembolism, Thrombosis, Unstable Angina, Venous (Vein) Thrombosis, Venous Thromboembolism
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke
Therapy area: Oncology. Indication: Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Oral Cavity (Mouth) Cancer, Squamous Cell Carcinoma